Target intelligence / Profile preview

Tumor-feeding arterial lumen

Molecular classification
Other
01

Overview

The tumor-feeding arterial lumen refers to the internal space of the arteries that specifically provide the blood supply, oxygen, and nutrients required for the growth and survival of a solid tumor (StatPearls, 2023). In interventional oncology, this anatomical structure is the primary route for regional therapies such as transarterial chemoembolization (TACE) and selective internal radiation therapy (SIRT) (National Cancer Institute). By targeting these specific vessels, clinicians can deliver high concentrations of chemotherapeutic agents or radioactive microspheres directly to the tumor while simultaneously obstructing blood flow to induce ischemia (Journal of Hepatology, 2016). While not a molecular target in the traditional sense, the identification and catheterization of the tumor-feeding arterial lumen are critical for the effective treatment of hypervascular malignancies, particularly hepatocellular carcinoma and certain metastatic liver cancers (PubMed, PMID: 27013391). The procedure relies on the differential blood supply of tumors compared to normal organ parenchyma, allowing for selective destruction of malignant tissue (RadiologyInfo.org).

Other names
Tumor-feeding arteryAfferent tumor vesselTumor-supplying arteryFeeding vessel
02

Mechanism of action

The lumen serves as a conduit for the delivery of embolic agents to induce ischemia and chemotherapeutic agents to provide localized cytotoxicity (StatPearls, 2023).

03

Biological functions

AngiogenesisBlood supplyNutrient deliveryOxygen transport
04

Disease associations

CancerHepatocellular carcinomaHypervascular tumors
05

Safety considerations

Non-target embolizationPost-embolization syndromeArterial dissectionIschemic injury to healthy tissue
06

Interacting drugs

Doxorubicin

6 more in the full profile.

07

Biomarkers

Arterial phase hyperenhancement (CT/MRI)Vascular Endothelial Growth Factor (VEGF)

Beyond the preview

Go deeper on Tumor-feeding arterial lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor-feeding arterial lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call